Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome

Thrombosis Research

Volumn 135, Issue 6, 2015, Pages 1191-1197

  Efthymiou, Maria ^a   Lawrie, Andrew S ^a   Mackie, Ian ^a   Arachchillage, Deepa ^a   Lane, Philip J ^a   Machin, Samuel ^a   Cohen, Hannah ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

amidolytic Factor X; INR; thrombin generation; Thrombotic antiphospholipid syndrome

Indexed keywords

BLOOD CLOTTING FACTOR 10; LUPUS ANTICOAGULANT; THROMBIN; THROMBOPLASTIN; WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTERIAL THROMBOEMBOLISM; ARTICLE; BLOOD EXAMINATION; CONTROLLED STUDY; DRUG MONITORING; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LAG TIME; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THROMBIN TIME; THROMBOCYTE POOR PLASMA; THROMBOTIC THROMBOCYTOPENIC PURPURA; ANTIPHOSPHOLIPID SYNDROME; ARTERY; BIOSYNTHESIS; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST; CHEMISTRY; CROSS-SECTIONAL STUDY; DRUG EFFECTS; MIDDLE AGED; PATHOLOGY; PROCEDURES; THROMBOSIS; VENOUS THROMBOEMBOLISM; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ARTERIES; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CROSS-SECTIONAL STUDIES; FACTOR X; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; PROTHROMBIN TIME; THROMBIN; THROMBOSIS; VENOUS THROMBOEMBOLISM; WARFARIN; YOUNG ADULT;

EID: 84929508119     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.03.030     Document Type: Article

References (40)

1. E.J. Favaloro, and D.M. Adcock Standardization of the INR: how good is your laboratory's INR and can it be improved? Semin Thromb Hemost 34 2008 593 603
2. S. Testa, G. Morstabilini, A. Fattorini, L. Galli, N. Denti, and A. D'Angelo Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system Haematologica 87 2002 1265 1273
3. A. D'Angelo, V.P. Della, L. Crippa, A. Fattorini, E. Pattarini, and D.S. Vigano Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment Haematologica 87 2002 1074 1080
4. I. Jennings, I.D. Walker, S. Kitchen, D. Kitchen, T.A. Woods, and D. Keeling Management of patients receiving oral anticoagulants using computer dosing software-does everyone agree? Data from a UK NEQAS (blood coagulation) exercise Int J Lab Hematol 34 2012 70 80
5. A. Robert, A. Le Querrec, B. Delahousse, C. Caron, L. Houbouyan, and B. Boutiere Control of oral anticoagulation in patients with the antiphospholipid syndrome-influence of the lupus anticoagulant on International Normalized Ratio. Groupe Methodologie en Hemostase du Groupe d'Etudes sur l'Hemostases et la Thrombose Thromb Haemost 80 1998 99 103
6. A. Crowl, A. Schullo-Feulner, and J.Y. Moon A Review of Warfarin Monitoring in Antiphospholipid Syndrome and Lupus Anticoagulant Ann Pharmacother 48 2014 1479 1483
7. A. Tripodi, V. Chantarangkul, M. Clerici, B. Negri, M. Galli, and P.M. Mannucci Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins Br J Haematol 115 2001 672 678
8. T.K. Rosborough, J.M. Jacobsen, and M.F. Shepherd Factor X and factor II activity levels do not always agree in warfarin-treated lupus anticoagulant patients Blood Coagul Fibrinolysis 21 2010 242 244
9. I.M. Costa, A.I. Serralheiro, M. Rodrigues, G. Alves, and A.C. Falcao Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy Biomed Pharmacother 64 2010 130 132
10. L.M. Baumann Kreuziger, Y.H. Datta, A.D. Johnson, N.D. Zantek, R. Shanley, and M.T. Reding Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing Blood Coagul Fibrinolysis 25 2014 232 236
11. D.L. McGlasson, B.G. Romick, and B.J. Rubal Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy Blood Coagul Fibrinolysis 19 2008 513 517
12. K. Varadi, P.L. Turecek, and H.P. Schwarz Thrombin generation assay and other universal tests for monitoring haemophilia therapy Haemophilia 10 Suppl. 2 2004 17 21
13. H.C. Hemker, P. Giesen, R. AlDieri, V. Regnault, S.E. de, and R. Wagenvoord The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability Pathophysiol Haemost Thromb 32 2002 249 253
14. M. Besser, C. Baglin, R. Luddington, V. Van Hylckama, and T. Baglin High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study J Thromb Haemost 6 2008 1720 1725
15. A. Tripodi The history of phenotypic testing in thrombosis and hemostasis Semin Thromb Hemost 34 2008 585 592
16. Y. Dargaud, M.C. Trzeciak, J.C. Bordet, J. Ninet, and C. Negrier Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype Thromb Haemost 96 2006 562 567
17. G. Hron, M. Kollars, B.R. Binder, S. Eichinger, and P.A. Kyrle Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation JAMA 296 2006 397 402
18. K. Devreese, K. Peerlinck, J. Arnout, and M.F. Hoylaerts Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography Thromb Haemost 101 2009 185 196
19. K. Devreese, K. Peerlinck, and M.F. Hoylaerts Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants Blood 115 2010 870 878
20. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, and R. Cervera International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
21. V. Pengo, A. Tripodi, G. Reber, J.H. Rand, T.L. Ortel, and M. Galli Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis J Thromb Haemost 7 2009 1737 1740
22. G. Ruiz-Irastorza, B.J. Hunt, and M.A. Khamashta A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies Arthritis Rheum 57 2007 1487 1495
23. R.S. Kasthuri, and R.A. Roubey Warfarin and the antiphospholipid syndrome: does one size fit all? Arthritis Rheum 57 2007 1346 1347
24. D. Keeling, I. Mackie, G.W. Moore, I.A. Greer, and M. Greaves Guidelines on the investigation and management of antiphospholipid syndrome Br J Haematol 157 2012 47 58
25. A.S. Lawrie, J. Hills, I. Longair, L. Green, C. Gardiner, and S.J. Machin The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients Thromb Res 130 2012 110 114
26. A.S. Lawrie, G. Purdy, I.J. Mackie, and S.J. Machin Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome Br J Haematol 98 1997 887 892
27. S.L. Perry, G.P. Samsa, and T.L. Ortel Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies Thromb Haemost 94 2005 1196 1202
28. P. Ferrazzi, A. Colombo, M.P. Di, C. Lodigiani, L. Libre, and L.L. Rota Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation J Blood Med 1 2010 57 60
29. D. Keeling, T. Baglin, C. Tait, H. Watson, D. Perry, and C. Baglin Guidelines on oral anticoagulation with warfarin fourth ed. Br J Haematol 154 2011 311 324
30. W. Ageno, A.S. Gallus, A. Wittkowsky, M. Crowther, E.M. Hylek, and G. Palareti Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e44S e88S
31. D.A. Hoppensteadt, S. Kahn, and J. Fareed Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs Clin Chem 43 1997 1786 1788
32. H.C. Hemker, D.R. Al, and de SE, Beguin S. Thrombin generation, a function test of the haemostatic-thrombotic system Thromb Haemost 96 2006 553 561
33. A. Gatt, J.J. van Veen, A. Bowyer, A.M. Woolley, P. Cooper, and S. Kitchen Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation Br J Haematol 142 2008 946 952
34. D.J. Arachchillage, M. Efthymiou, I. Mackie, A. Lawrie, S. Machin, and H. Cohen Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome J Thromb Haemost 12 2014 1801 1809
35. S. Liestol, P.M. Sandset, E.M. Jacobsen, M.C. Mowinckel, and F. Wisloff Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants Br J Haematol 136 2007 131 137
36. Y. Sheng, J.G. Hanly, S.W. Reddel, S. Kouts, J. Guerin, and T. Koike Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin Clin Exp Immunol 124 2001 502 508
37. J.G. Hanly, and S.A. Smith Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome J Rheumatol 27 2000 2152 2159
38. M.J. Adams, S. Donohoe, I.J. Mackie, and S.J. Machin Anti-tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome Br J Haematol 114 2001 375 379
39. M. Adams, L. Breckler, P. Stevens, J. Thom, R. Baker, and R. Oostryck Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation Haematologica 89 2004 985 990
40. Y.H. Yang, K.K. Hwang, J. FitzGerald, J.M. Grossman, M. Taylor, and B.H. Hahn Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin J Immunol 177 2006 8219 8225